SLS Reports $71.8M Cash, $42.6M Q1 Proceeds, Advances GPS Phase 3 REGAL Trial to 80 Events, Launches SLS009 Expansion in AML
SELLAS Life Sciences Group, Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $9.07
Post-detection moves
1h
—
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS